1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Chronic Cough Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Chronic Cough Clinical Trials by Region
2.2.2 Average Enrollment of Chronic Cough Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Chronic Cough Treatment, 2019

3. Region wise Chronic Cough Clinical Trials
3.1 Asia Pacific Chronic Cough Clinical Trials by Country
3.2 Europe Chronic Cough Clinical Trials by Country
3.3 North America Chronic Cough Clinical Trials by Country
3.4 Middle East and Africa Chronic Cough Clinical Trials by Country
3.5 South and Central America Chronic Cough Clinical Trials by Country

4. Chronic Cough Clinical Trial Trends
4.1 Start Year wise Chronic Cough Clinical Trials
4.2 Phase wise Chronic Cough Clinical Trials
4.3 Trial Status wise Chronic Cough Clinical Trials
4.4 Trial Type wise Chronic Cough Clinical Trials

5. Chronic Cough Average Enrollment Trends
5.1 Average Enrollment in Chronic Cough Trials by Year
5.2 Average Enrollment in Chronic Cough Trials by Phase
5.3 Average Enrollment in Chronic Cough Trials by Status
5.4 Average Enrollment in Chronic Cough Trials by Type of Trial

6. Companies Participating in Chronic Cough Clinical Trials
6.1 Chronic Cough Trials by Sponsor Type
6.2 Chronic Cough Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Chronic Cough Trials- Phase 1
7.2 Chronic Cough Trials- Phase 2
7.3 Chronic Cough Trials- Phase 3
7.4 Chronic Cough Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Chronic Cough Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Chronic Cough Clinical Trials and Enrolment
Figure 5: Europe – Country wise Chronic Cough Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Chronic Cough Clinical Trials and Enrolment
Figure 7: North America – Country wise Chronic Cough Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Chronic Cough Clinical Trials and Enrolment
Figure 9: Chronic Cough Clinical Trials by Phase
Figure 10: Chronic Cough Clinical Trials by Trial Status
Figure 11: Chronic Cough Clinical Trials by Type
Figure 12: Chronic Cough Clinical Trials by Sponsor Type
Figure 13: Chronic Cough Clinical Trials by Leading Sponsors
Figure 14: Chronic Cough Average Enrollment by Phase
Figure 15: Chronic Cough Average Enrollment by Trial Status
Figure 16: Chronic Cough Average Enrollment by Type
Figure 17: Chronic Cough- Average Enrolment by Type of Sponsors
Figure 18: Chronic Cough- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List of Tables
Table 1: Chronic Cough Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Chronic Cough Clinical Trials and Enrolment
Table 5: Europe – Country wise Chronic Cough Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Chronic Cough Clinical Trials and Enrolment
Table 7: North America – Country wise Chronic Cough Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Chronic Cough Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Chronic Cough Average Enrollment by Phase
Table 15: Chronic Cough Average Enrollment by Trial Status
Table 16: Chronic Cough Average Enrollment by Type
Table 17: Chronic Cough- Average Enrolment by Type of Sponsors
Table 18: Chronic Cough- Enrolment by Leading Sponsors

Companies mentioned
Afferent Pharmaceuticals Inc, AstraZeneca Plc, BELLUS Health Inc, Celgene Corp, Cerecor Inc, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd, Isala Klinieken, Lambda Therapeutic Research Ltd, Patara Pharma Inc